Form 8-K - Current report:
SEC Accession No. 0001477932-21-005338
Filing Date
2021-08-11
Accepted
2021-08-11 16:12:12
Documents
2
Period of Report
2021-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT vnrx_8k.htm 8-K 18342
2 EXHIBIT 99.1 PRESS RELEASE OF VOLITIONRX LIMITED, DATED AUGUST 11, 2021 vnrx_ex991.htm EX-99.1 39358
  Complete submission text file 0001477932-21-005338.txt   58977
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 211163547
SIC: 2835 In Vitro & In Vivo Diagnostic Substances